Cary Twyman - Concepedia

Author

Cary Twyman

Associates in Neurology ORCID

Also Known As

Ben W. Thrower, C. Twyman, C.L. Twyman, Cary L Twyman, Cary L. Twyman, Cary Twyman

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Associates in Neurology Charles University Heinrich Heine University Düsseldorf McGill University University of Cambridge

About

Cary Twyman is an author at Associates in Neurology specializing in medicine, multiple sclerosis, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.6K
2	Engineering	1	1	38
3	Natural Sciences	1	1	38
4	Allergy	1	1	47
5	Biochemistry	1	1	38

Cary Twyman

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alasdair Coles, Cary Twyman, Douglas L. Arnold, The Lancet ImmunologyClinical TrialsNeurological ProgressDisease-modifying TherapyMultiple Sclerosis	2012	1.2K
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, The Lancet Neurology Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology	2018	327
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients Amy E. Lovett‐Racke, Matthew Gormley, Yue Liu, Journal of Neuroimmunology Adaptive Immune SystemT-regulatory CellImmunologyImmune RegulationPathology	2019	47
Acidities and homolytic bond dissociation energies (BDEs) of benzyl-type carbon-hydrogen bonds in sterically congested substrates F. G. Bordwell, Jin Cheng, A. V. Satish, The Journal of Organic Chemistry EngineeringAltmetric Attention ScoreOrganic ChemistryComputational ChemistryChemistry	1992	38
Durable Efficacy of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Who Participated in the CARE-MS Studies: Three Year Follow-Up (S41.001) Edward Fox, Douglas L. Arnold, Jeffrey Cohen, Neurology	2013	13
Thyroid Autoimmune Adverse Events in Patients Treated with Alemtuzumab for Relapsing-remitting Multiple Sclerosis: Four-year Follow-up of the CARE-MS Studies (P2.199) Cary Twyman, Pedro Oyuela, Jeffrey Palmer, Neurology	2014	13
A giant MS plaque mimicking PML during natalizumab treatment Cary Twyman, Joseph R. Berger Journal of the Neurological Sciences VasculitisAutoimmune DiseasePathologyTherapeutic EfficacyMultiple Sclerosis	2010	12

Page 1